“Innovation is key to fuelling the fight for health equity in low- and middle-income countries” - PATH’ Melanie Saville looks at five game-changing steps that would make a huge difference towards achieving #healthforall : bit.ly/3VuUGYn #healthforall Via World Economic Forum

Researchers have created a nanovaccine that can produce the B cells that create antibodies capable of neutralising the #HIV virus. Here’s what you need to know: bit.ly/4aSNeLh

Did you know that breastfeeding improves a child’s response to routine immunisation? Combined, vaccines and breastmilk are the two “most cost-effective ways to lower infant and child mortality”: bit.ly/3Xssgjp

“We believe that the five decades of the EPI have also contributed to the decline in infant and neonatal mortality in Cameroon” - Dr Tchokfe Shalom outlines the progress achieved in Cameroon on the 50th anniversary of its Expanded Program on Immunization: bit.ly/4bPMs2Q

In April 2024, nearly 10,000 Gavi-funded rapid diagnostic testing kits for #cholera landed in Lilongwe, Malawi. Health leaders and frontline workers say they’re making a major difference in the fight to #stopcholera : bit.ly/3RhUYzc

The Gavi Board concluded today with the approval of the most ambitious strategy in Gavi’s history: seeking to protect more people, against more diseases, faster than ever. Here are 5 things you need to know about our new five-year strategy: bit.ly/4eesPmM

Low- and middle-income countries disproportionately bear the burden of health inequity. From #AI to robust regional manufacturing, here's how innovation can help achieve #healthequity : bit.ly/3VuUGYn #healthforall Via World Economic Forum

Unprecedented crises and global health threats call for bold strategies. In a complex and changing world, I’m proud that today the Gavi Board has set the most ambitious strategy in @Gavi’s history:  bit.ly/3KTnjsp

Hon. Minister Dr. Jane Ruth Aceng Ocero today received Mr. Xavier Sticker ahead of Government of Uganda's participation in the African Vaccine Manufacturing Accelerator (AVMA) launch & Gavi’s 2026–2030 Investment Opportunity that France will co-host with African Union, Gavi, the Vaccine Alliance & #TeamEurope partners.

Cutting-edge research into nanoparticles produced “rare but powerful” antibodies capable of neutralising the #HIV virus. Learn about this “encouraging step in developing a preventative HIV vaccine: bit.ly/4aSNeLh

Health workers receive certification based on classroom learning and exams but when thrust into the real world, they rapidly learn that their learning is far from complete. Hear from health workers about the importance of “continuous learning”: bit.ly/3RfDFiu

In Kenya, the proportion of babies being fed exclusively on breastmilk has risen from just 13 percent in 1998, to 60 percent in 2022. Learn how this trend has helped drive down rates of early childhood mortality: bit.ly/3Xssgjp

As Cameroon celebrates the 50th anniversary of its Expanded Program on Immunization, Dr Tchokfe Shalom Ndoula, Permanent Secretary of the EPI, looks back over progress achieved, and casts an eye up the road ahead: bit.ly/4bPMs2Q #HumanlyPossible

A new report from Malaria No More UK ranks the UK as the second largest funder of malaria research and development globally. Through continued investment in @Gavi and The Global Fund's programmes we can work together to #endmalaria : bit.ly/4aSKayL

Super proud of our SC Members for bringing CSO voices to the forefront during their recent meeting with the Gavi, the Vaccine Alliance CEO! We stand witness to Dr Sania Nishtar's commitment and leadership, seizing this opportunity for continued collaboration.